Clinical Trial Update: Rituximab Combined With Prior Therapy in Advanced Hepatocellular Carcinoma: Efficacy & Safety Study [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating rituximab in combination with prior therapy for advanced hepatocellular carcinoma is currently recruiting to assess efficacy and safe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Rituximab (rituximab)

Snippet

Sponsor: Tianjin Medical University Cancer Institute and Hospital | Conditions: Advanced Hepatocellular Carcinoma | Phase 2 | Status: RECRUITING